Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)Safety Study for Treatment of Wet Macular Degeneration Using the TheraSight(TM) Ocular Brachytherapy System
Phase 1
- Conditions
- Macular DegenerationChoroidal Neovascularization
- First Posted Date
- 2004-12-23
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- Theragenics Corporation
- Target Recruit Count
- 30
- Registration Number
- NCT00100087
- Locations
- 🇺🇸
Theragenics Clinical Site, Raleigh / Durham, North Carolina, United States
News
No news found